A detailed history of Health Invest Partners Ab transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Health Invest Partners Ab holds 82,691 shares of IONS stock, worth $2.81 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
82,691
Previous 40,691 103.22%
Holding current value
$2.81 Million
Previous $1.94 Million 70.81%
% of portfolio
1.61%
Previous 1.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $1.68 Million - $2.18 Million
42,000 Added 103.22%
82,691 $3.31 Million
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $841,995 - $1.1 Million
-23,100 Reduced 36.21%
40,691 $1.94 Million
Q1 2024

Apr 25, 2024

BUY
$42.03 - $53.55 $1.66 Million - $2.12 Million
39,548 Added 163.13%
63,791 $2.77 Million
Q4 2023

Jan 30, 2024

BUY
$43.39 - $51.63 $1.05 Million - $1.25 Million
24,243 New
24,243 $1.23 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.